Novartis Receives Approval In The European Union For Menveo, F...
Source: Congoo
Thursday 18th March, 2010
Company: Novartis AG (NVS) Novartis International AG / Novartis receives approval in the European Union for Menveo(R), first quadrivalent conjugate vaccine in the EU to help prevent meningococcal dise... ...
Read the full story at
Congoo
Email this story to a friend
Have your say on this story
